On February 25, the U.S. Preventive Services Task Force (USPSTF) posted its final recommendation statement on vitamin, mineral and multivitamin supplements for the prevention of cardiovascular disease and cancer. In the statement, the USPSTF concluded there is not enough evidence to determine the effectiveness of taking vitamins and minerals to prevent cardiovascular disease or cancer. “Cardiovascular disease and cancer have a significant health impact in America, and we all want to find ways to prevent these diseases,” said USPSTF Chair Virginia Moyer, MD, MPH. “However, we found that there is not enough evidence to determine whether taking single or paired nutrients or a multivitamin helps to prevent cardiovascular disease or cancer.”
Additionally, there are two vitamins that the USPSTF recommends against using: beta-carotene and vitamin E. According to USPSTF, this is a D grade recommendation. “The evidence shows that there is no benefit to taking vitamin E and that beta-carotene can be harmful because it increases the risk of lung cancer in people who are already at increased risk for the disease,” said Michael LeFevre, MD, MSPH, USPSTF co-chair. “Due to the uncertain benefit of vitamin supplements to prevent cardiovascular disease and cancer, health care professionals should use their best judgment and consider their patient’s health history, values and preferences when having conversations about nutritional supplements.”
In response to USPSTF’s recommendations, the Council for Responsible Nutrition (CRN) released the following statement:
“We commend the Task Force for wisely recognizing that nutrients are not drugs, acknowledging that there are significant challenges to studying vitamins using methods similar to those used for studying pharmaceutical interventions,” said Duffy MacKay, ND, CRN’s senior vice president of scientific and regulatory affairs. “Importantly, the final report calls for new and innovative research methodologies, which is in contrast to the suggestion by a medical journal that called for the end of vitamin research when the draft report was published. We strongly support both the need for more research and the need for the scientific community to come to terms with a rigorous approach to studying nutrition that may not reflect the current model of studying drugs. In the meantime, there are real-life reasons why people should take vitamins and why so many doctors recommend them.”For more information, visit www.uspreventiveservicestaskforce.org or www.crnusa.org.
VIRGO (Phoenix, AZ) has announced that it has changed the name of SupplySide Marketplace to Ingredient MarketPlace, a SupplySide event. This year’s Expo is set for June 2-3, 2014 at the Jacob Javits Center in New York, NY.
Exhibitors will have storefronts instead of traditional booths, which will allow attendees to shake hands and meet the innovators behind the ingredient categories that are defining their products. The trade show will give buyers and suppliers an opportunity to network and create partnerships to fuel new products.
Feedback from last year’s attendees shows their desire to learn more about trends in different categories. This year’s hottest categories and “Trends In” presentations will include 30-minute reports on: omega-3s, probiotics, protein, amino acids, magnesium, sweeteners, antioxidants, vitamin E and carotenoids. The presentations are designed to help marketers and formulators differentiate their products, obtain market research on purchasing trends and sales, and discover examples of how the ingredients are being used in the global market.For more information, visit http://marketplace.supplysideshow.com.
BioPerine® from Sabinsa (East Windsor, NJ) is a patented standardized extract from black pepper, containing not less than 95 percent piperine. It is a clinically proven bioavailability enhancer for nutrients. It shows increased blood supply to the GI tract, increased emulsifying content of the gut and increased active nutrient transport. BioPerine improves the absorption of CoQ10, curcumin, vitamins B6, B12 and D, as well as many others.
For more information, call (732) 777-1111 or visit www.sabinsa